Results 21 to 30 of about 655,167 (267)

Comparison of Three Phenotypic Methods of Carbapenemase Enzyme Detection to Identify Carbapenem-resistant Enterobacterales

open access: yes, 2022
The prevalence of multidrug-resistant gram-negative bacilli has increased worldwide. Critical care areas of most hospitals use carbapenem antibiotics for the empirical treatment of gram-negative bacterial (GNB) infections.
K.V. Leela   +3 more
core   +1 more source

Carbapenem-resistant gram-negative bacterial prevention practice in nosocomial infection and molecular epidemiological characteristics in a pediatric intensive care unit

open access: yesHeliyon, 2023
Introduction: The increasing prevalence of carbapenem-resistant gram-negative bacilli infection has emerged as a substantial threat to human health.
Lijun Yin   +10 more
doaj   +1 more source

Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center

open access: yesJournal of Microbiology, Immunology and Infection, 2019
Background: Acquired carbapenem resistance among non-fermenting Gram-negative bacilli (NFGNB), such as Pseudomonas aeruginosa and Acinetobacter calcoaceticus-Acinetobacter baumannii complex (ACB complex), is a serious problem in nosocomial infections. We
Ying-Chi Huang   +3 more
doaj   +1 more source

Carbapenem resistance in the food supply chain

open access: yesJournal of Food Protection, 2023
Carbapenems are critically important antibiotic agents because they are considered the "last-resort" antibiotics for treating serious infections. However, resistance to carbapenems is increasing throughout the world and has become an urgent problem.
En Huang   +3 more
openaire   +3 more sources

Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend

open access: yesInternational Journal of Infectious Diseases, 2019
Background: Bacteraemia due to carbapenem-resistant gram-negative bacteria is challenging. This study examined the burden of carbapenem and colistin resistance in Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii bacteraemia in ...
A. Balkhair   +7 more
doaj   +1 more source

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention [PDF]

open access: yesClinical Infectious Diseases, 2011
Over the past 10 years, dissemination of Klebsiella pneumoniae carbapenemase (KPC) has led to an increase in the prevalence of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Infections caused by CRE have limited treatment options and have been associated with high mortality rates. In the previous year, other carbapenemase subtypes,
Neil, Gupta   +3 more
openaire   +2 more sources

Carbapenem-Resistant Enterobacteriaceae Infections in Children [PDF]

open access: yesCurrent Infectious Disease Reports, 2015
Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. Infections due to CRE are associated with significant morbidity and mortality. Few therapeutic options are available for treatment of these infections, and optimal antibiotic treatment regimens are unclear.
Kathleen, Chiotos   +2 more
openaire   +2 more sources

Prevalence of Carbapenem-Resistant Enterobacteriaceae and the Genes Responsible for Carbapenemase Production in a Tertiary Care Hospital in South India [PDF]

open access: yes, 2023
Introduction: Carbapenem resistance in Gram-negative bacilli (GNB) is a major concern in the management of resistant infections. The mechanism of carbapenem resistance is most commonly mediated by carbapenemases. The five most common genes (NDM, KPC, VIM,
Archana Mahalingam   +5 more
core   +1 more source

Aminoglycoside-modifying Enzymes in Carbapenem-resistant Pseudomonas aeruginosa Clinical Isolates

open access: yesMediterranean Journal of Infection, Microbes and Antimicrobials, 2022
Introduction: Aminoglycosides are the drug of choice for the treatment of Pseudomonas aeruginosa infections. Aminoglycoside resistance in P. aeruginosa often occurred via acquired aminoglycoside-modifying enzymes (AMEs).
Yeliz TANRIVERDİ ÇAYCI   +6 more
doaj   +1 more source

Individualized active surveillance for carbapenem-resistant microorganisms using Xpert Carba-R in intensive care units

open access: yesScientific Reports, 2023
Carbapenem antibiotics are widely used in ICU, and the prevalence of carbapenem-resistant microorganisms (CRO) has increased. This study aimed to assess the role of individualized active surveillance using Xpert Carba-R of carbapenem resistance genes on ...
Shuliang Zhou   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy